Katinger; Hermann
Patent Applications and Registrations
Patent applications and USPTO patent grants for Katinger; Hermann.The latest application filed is for "recombinant human igm-antibody effective against cancer cells".
- Katinger; Hermann - Vienna AT
- KATINGER; Hermann - Wien AT
- Katinger; Hermann - AT AT
| Patent | Date |
|---|---|
| Recombinant human IgM-antibody effective against cancer cells Grant 10,590,204 - Katinger , et al. | 2020-03-17 |
| RECOMBINANT HUMAN IgM-ANTIBODY EFFECTIVE AGAINST CANCER CELLS App 20180237538 - KATINGER; Hermann ; et al. | 2018-08-23 |
| Recombinant human IgM-antibody effective against cancer cells Grant 9,920,130 - Katinger , et al. March 20, 2 | 2018-03-20 |
| RECOMBINANT HUMAN IgM-ANTIBODY EFFECTIVE AGAINST CANCER CELLS App 20150322161 - KATINGER; Hermann ; et al. | 2015-11-12 |
| Liposomal composition comprising an active ingredient for relaxing smooth muscle, the production of this composition and the therapeutic use thereof Grant 8,524,274 - Wagner , et al. September 3, 2 | 2013-09-03 |
| Liposomal Composition Comprising An Active Ingredient For Relaxing Smooth Muscle, The Production Of This Composition And The Therapeutic Use Thereof App 20090324698 - Wagner; Andreas ; et al. | 2009-12-31 |
| Anti-idiotypic monoclonal antibody reactive with HIV neutralizing antibody 2F5 Grant 7,625,566 - Kunert , et al. December 1, 2 | 2009-12-01 |
| IGG1 monoclonal antibody with anti-HIV neutralizing activity Grant 7,595,049 - Stiegler , et al. September 29, 2 | 2009-09-29 |
| Live attenuated influenza vaccine Grant 7,494,659 - Katinger , et al. February 24, 2 | 2009-02-24 |
| Superloaded Liposomes for Drug Delivery App 20080113015 - Katinger; Hermann ; et al. | 2008-05-15 |
| Method for the manufacture of recombinant trypsin Grant 7,351,549 - Mattanovich , et al. April 1, 2 | 2008-04-01 |
| Tumor and senescence marker Grant 7,202,352 - Katinger , et al. April 10, 2 | 2007-04-10 |
| Bioactive oligopeptides Grant 7,101,664 - Katinger , et al. September 5, 2 | 2006-09-05 |
| Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies App 20050080240 - Kunert, Renate ; et al. | 2005-04-14 |
| Method and device for producing lipid vesicles Grant 6,843,942 - Katinger , et al. January 18, 2 | 2005-01-18 |
| Peptides mimicking a cryptic epitope of gp41 hiv-1 App 20040241641 - Stiegler, Gabriela M ; et al. | 2004-12-02 |
| Live vaccine and method of manufacture App 20040137013 - Katinger, Hermann ; et al. | 2004-07-15 |
| Tumor and senescence marker App 20040086963 - Katinger, Hermann ; et al. | 2004-05-06 |
| Bioactive oligopeptides App 20040072341 - Katinger, Hermann ; et al. | 2004-04-15 |
| Method and device for producing lipid vesicles App 20040032037 - Katinger, Hermann ; et al. | 2004-02-19 |
| Method for the manufacture of recombinant trypsin App 20030157634 - Mattanovich, Diethard ; et al. | 2003-08-21 |
| Application of SOD in liposomes Grant 5,942,245 - Katinger , et al. August 24, 1 | 1999-08-24 |
| HIV-vaccines Grant 5,911,989 - Katinger , et al. June 15, 1 | 1999-06-15 |
| Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,866,694 - Katinger , et al. February 2, 1 | 1999-02-02 |
| Human monoclonal anti-HIV-I-antibodies Grant 5,831,034 - Katinger , et al. November 3, 1 | 1998-11-03 |
| Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,756,674 - Katinger , et al. May 26, 1 | 1998-05-26 |
| Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates Grant 5,693,752 - Katinger , et al. December 2, 1 | 1997-12-02 |
| Method of and an arrangement for cultivating cells of animal and human tissues Grant 4,311,798 - Katinger , et al. * January 19, 1 | 1982-01-19 |
| Method of cultivating cells of animal and human tissues Grant 4,259,449 - Katinger , et al. March 31, 1 | 1981-03-31 |
| Device for cultivating cells of animal and human tissues Grant 4,173,516 - Katinger , et al. November 6, 1 | 1979-11-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 